Reversible peripartum liver failure: A new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases
Ma. Castro et al., Reversible peripartum liver failure: A new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases, AM J OBST G, 181(2), 1999, pp. 389-395
OBJECTIVE: We sought to describe our experience with the clinical diagnosis
, management, and course of patients with acute fatty liver of pregnancy.
STUDY DESIGN: Twenty-eight cases of acute fatty liver of pregnancy at the L
os Angeles County and University of Southern California Medical Center from
1982 to June 1997 were identified, and presenting symptoms, clinical cours
e, laboratory values, maternal complications, and neonatal outcomes were st
udied.
RESULTS: The incidence of acute fatty liver of pregnancy was 1 in 6659 birt
hs. There were no maternal deaths. Initial presentation was at an average o
f 37 weeks of gestation with a characteristic prodrome of malaise, nausea,
vomiting, and abdominal pain. No patient was admitted with the diagnosis of
acute fatty liver of pregnancy. The condition was diagnosed most commonly
on the second hospital day after laboratory results indicated coagulopathy,
renal insufficiency, and liver function abnormalities. One patient underwe
nt liver biopsy at cesarean delivery. Radiologic studies did not aid with t
he diagnosis. Twenty-one patients were admitted in spontaneous labor, and 1
6 labors were complicated by abnormal fetal heart rate patterns or meconium
. There was 1 stillbirth and 1 neonatal death as a result of perinatal asph
yxia. Maternal morbidity consisted of hypoglycemia, infection, renal insuff
iciency, coagulopathy, encephalopathy, and wound complications. All patient
s had evidence of disseminated intravascular coagulopathy with profoundly d
ecreased antithrombin levels. All patients recovered normal liver function
post partum.
CONCLUSIONS: Reversible peripartum liver failure may be diagnosed and manag
ed on the basis of clinical and laboratory criteria. With adequate support,
these patients may have full recovery of hepatic function.